Ramalingam Ajit
- SEC CIK
- 0001807891
No open-market purchases or sales filed in the past year.
Current role at each company
- BIO Bio-Rad Laboratories, Inc.SVP, Chief Accounting Officeras of Sep 6, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ramalingam Ajit as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2023 (view filing) | Jun 6 | 1 day | Ramalingam AjitSVP, Chief Accounting Officer | SSaleBio-Rad A Common Stock | −198.35 | $368.30 | −$73.1K | −100.0%0 after | 2 lots |
| Nov 14, 2022 (view filing) | Nov 10 | 4 days | Ramalingam AjitSVP, Chief Accounting Officer | SSaleBio-Rad A Common Stock | −379.38 | $421.87 | −$160.1K | −100.0%0 after | 3 lots |
| Aug 8, 2022 (view filing) | Aug 5 | 3 days | Ramalingam AjitSVP, Chief Accounting Officer | SSaleBio-Rad A Common Stock | −518 | $537.00 | −$278.2K | −84.0%98.5 after |